Immuneering reports Q1 2026 financial results and clinical updates
Go back to Immuneering reports Q1 2026 financial results and clinical updates| ImaRx Therapeutics, Inc. (NASDAQ: IMRX) | Delayed: 5.30 +0.05 (0.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.25 | 52 Week High | $0.04 | |||
| Open | $5.31 | 52 Week Low | $0.00 | |||
| Day High | $5.43 | P/E | N/A | |||
| Day Low | $5.28 | EPS | $-0.09 | |||
| Volume | 445,566 | |||||
| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 37.34 +0.53 (1.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.81 | 52 Week High | $66.55 | |||
| Open | $36.79 | 52 Week Low | $37.82 | |||
| Day High | $37.75 | P/E | N/A | |||
| Day Low | $36.65 | EPS | $0.00 | |||
| Volume | 4,300,152 | |||||
